News | July 12, 2025
Senores Pharmaceuticals to increase stake in Havix
Havix is a US based company engaged in the business of developing, manufacturing and supplying of various finished formulations
Havix is a US based company engaged in the business of developing, manufacturing and supplying of various finished formulations
Emcure Pharmaceuticals successfully completes USFDA PAI of Oncology facility
IGI partners with AbbVie and grants exclusive rights to globally develop, manufacture, and commercialize ISB 2001 across North America, Europe, Japan, and Greater China
Azelis will strengthen its presence in the domestic market by leveraging portfolio synergies, actively consolidating the business, and creating value for all stakeholders
Apollo AyurVAID’s product line features clinically proven formulations certified safe by NABL-accredited laboratories for heavy metals, aflatoxins, microbial content
This year, 40 women students are participating, selected through a rigorous process evaluating academic merit, research interest, and socio-economic background
The UK authorization is based on positive results from the Phase III OASIS-1, -2, and -3 trials
Xtandi is approved in over 80 countries, including the U.S., EU, and Japan
Acquisition aligns with Merck’s science-led business development strategy and expands pipeline and portfolio of treatments for cardio-pulmonary diseases
Lupin and Zentiva sign license and supply agreement for commercializing Certolizumab
Subscribe To Our Newsletter & Stay Updated
